查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948992

管瓶适配器市场：按最终用户、交付方式、分销管道、材料和应用划分，全球预测，2026-2032年

Vial Adapter Market by End User, Delivery Mode, Distribution Channel, Material, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年，管瓶转接器市值为 8.0517 亿美元，预计到 2026 年将成长至 8.296 亿美元，年复合成长率为 6.91%，到 2032 年将达到 12.8547 亿美元。

关键市场统计数据
基准年 2025 8.0517亿美元
预计年份：2026年 8.296亿美元
预测年份 2032 12.8547亿美元
复合年增长率 (%) 6.91%

一份简明策略概述，阐述了管瓶适配器设计、临床效用和采购重点，旨在帮助经营团队进行决策和製定产品策略。

管瓶适配器是药品与给药系统之间的关键接口，可在临床和非临床环境中安全且有效率地取得管瓶内容物。本执行摘要整合了对竞争格局、技术演进、监管互动和供应链趋势的策略洞察，旨在揭示影响价值链各相关人员采购、设计决策和商业化策略的因素。本概要针对高阶管理人员、产品负责人、采购人员和临床营运团队，协助他们将投资与实际实施路径结合。

深入检验正在重新定义管瓶适配器产品预期和供应链优先事项的技术、监管和采购方面的整合变化。

管瓶适配器市场正面临多重同步变化，这些变化正在重塑产品蓝图和商业性策略。技术成熟度的提升，包括安全设计和自动加药介面的广泛应用，显着推动了先进医疗环境中此类产品的普及。同时，材料科学的进步使得轻量化、符合人体工学的组件成为可能，从而减少了医疗设备相关废弃物，并改善了临床和家庭环境中的操作体验。

从分析观点探讨不断变化的关税趋势对管瓶适配器相关人员的筹资策略、製造地和分销韧性的影响

近期主要进口国的贸易措施和关税调整对支持管瓶适配器生产和分销的供应链产生了广泛影响。关税调整凸显了供应链多元化的重要性，促使许多企业重新评估其采购、製造地和库存策略，以降低跨境成本波动带来的风险。为此，采购部门正在加快供应商资质审核流程，并优先考虑多种采购方案，以确保供应的连续性。

透过对终端用户环境、产品类型、供应模式、分销管道结构、材料选择和临床应用等因素进行综合細項分析，实现策略性产品定位。

要了解市场动态，需要从细分市场的观点出发，将设计和商业化与具体的应用情境和采购管道连结起来。依最终用户划分，诊所、居家医疗机构和医院系统的采用模式各不相同，而医院的需求又会根据规模小规模进一步细分。大型医院通常优先考虑整合安全功能和批量采购管道，而小规模医院则倾向于寻求经济高效且易于实施的解决方案。产品类型分为传统型和安全工程型。由于规避风险的临床通讯协定和针刺预防事故计画的推行，安全设备正日益受到关注。

从区域观点，分析美洲、欧洲、中东和非洲以及亚太市场的采用驱动因素、监管差异和分销模式。

区域趋势对竞争优势、供应商策略和实施时间表有显着影响，应体现在市场进入和扩张计画中。在美洲，完善的采购流程和一体化的医院系统为能够提供强有力的临床证据、一体化供应方案和可靠物流的供应商创造了机会。区域分销网络和联合采购模式往往会促使供应商期望签​​订长期合约并附加价值服务。在欧洲、中东和非洲地区，监管环境的多样性以及集中式和分散式采购模式的混合，要求供应商采取适应性强的合规策略和灵活的商业性策略，尤其是在各国卫生机构制定各自的兼容性和灭菌标准的情况下。

深入了解领先製造商与创新新参与企业在管瓶适配器领域的竞争定位、伙伴关係模式和营运能力的差异

管瓶适配器领域的竞争格局由成熟的医疗设备製造商、专业组件供应商以及专注于安全性和自动化的创新新兴参与企业组成。市场领导通常透过整合的品质系统、广泛的监管覆盖以及可靠的物流和上市后监测能力来支持大型机构合同，从而脱颖而出。新兴企业则以敏捷性取胜，它们通常会推出模组化或数位化解决方案，以快速回应临床回馈和特定应用场景。

为製造商和供应商提供切实可行的策略建议，以加强通路合作，从而提升安全性、增强供应链韧性、产生临床证据并推动产品应用。

产业领导者应优先考虑切实可行的措施，使设计选择、供应链韧性和商业模式与临床和采购的实际情况相符。首先，在设计生命週期的早期阶段就应纳入安全性和相容性测试，以减少下游监管方面的阻力，并提升客户价值提案。其次，应实现关键零件供应商多元化，并考虑策略性近岸外包和区域组装，以缩短前置作业时间，同时降低运输和关税相关的风险。

采用透明的多方法调查方法，整合相关人员访谈、监管分析和供应链图谱，以检验策略洞察和建议。

本执行摘要的分析是基于多方面的研究方法，整合了主要相关利益者访谈、二手文献综述、监管文件分析和供应链图谱。主要研究透过与采购主管、临床终端使用者、产品开发专业人员和分销合作伙伴的结构化对话，揭示了实用化障碍、偏好驱动因素和服务期望。二级资讯来源包括监管指南、行业最佳实践文件、技术标准以及近期关于医疗设备安全性、材料相容性和临床工作流程的同行评审文献。

总之，我们强调以安全驱动的设计、供应链的柔软性和循证实施为基础的综合观点，作为管瓶适配器相关人员获得可持续竞争优势的基础。

总之，管瓶适配器相关人员面临着日益增长的安全期望、材料和设计创新、采购行为的转变以及对具有韧性和灵活性的供应链的需求等挑战。那些将产品开发与严格的相容性测试相结合、建立多元化筹资策略并设计针对不同终端使用者环境量身定制的通路模式的公司，将更有利于获得机构和临床的持续认可。此外，与负责人积极合作检验加大对实证医学的投入，将有助于加速产品融入诊断和治疗流程。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依最终用户管瓶转接器市场

  • 诊所
  • 居家照护
  • 医院

第九章 依给药方式管瓶转接器市场

  • 自动的
  • 手动的

第十章 按分销管道分類的管瓶适配器市场

  • 离线
  • 在线的

第十一章 依材料管瓶转接器市场

  • 金属
  • 塑胶

第十二章管瓶适配器市场按应用领域划分

  • 诊断
    • 血液检查
    • 疫苗接种
  • 治疗
    • 药物输送
    • 免疫疗法

第十三章 区域性管瓶转接器市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章管瓶转接器市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国管瓶转接器市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国管瓶转接器市场

第十七章：中国管瓶适配器市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agilent Technologies Inc.
  • Amsino International Inc.
  • ARaymond
  • B. Braun SE
  • Baxter International Inc.
  • Becton Dickinson and Company（BD）
  • Cardinal Health, Inc.
  • Corvida Medical
  • Dedecke GmbH
  • EQUASHIELD LLC
  • Gerresheimer
  • Helapet Limited
  • ICU Medical
  • MedXL Inc.
  • Miltenyi Biotec BV & Co. KG
  • Nipro Corporation
  • Simplivia Healthcare Ltd.
  • Stevanato Group SpA
  • Union Plastic SAS
  • West Pharmaceutical Services, Inc.
Product Code: MRR-4F7A6D4FB92F

The Vial Adapter Market was valued at USD 805.17 million in 2025 and is projected to grow to USD 829.60 million in 2026, with a CAGR of 6.91%, reaching USD 1,285.47 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 805.17 million
Estimated Year [2026] USD 829.60 million
Forecast Year [2032] USD 1,285.47 million
CAGR (%) 6.91%

A concise strategic introduction that frames vial adapter design, clinical utility, and procurement priorities to inform executive decision-making and product strategy

Vial adapters are an essential interface between pharmaceutical products and delivery systems, enabling safe, efficient access to vial contents across clinical and non-clinical settings. This executive summary synthesizes strategic insights about the competitive environment, technology evolution, regulatory interactions, and supply chain dynamics that will influence procurement, design decisions, and commercialization strategies for stakeholders across the value chain. It is intended for senior executives, product strategists, procurement leaders, and clinical operations teams seeking to align investments with practical adoption pathways.

Beginning with an overview of current technology trends and procurement drivers, the narrative traces how safety priorities, materials selection, and channel dynamics interact with clinical applications such as diagnostic sampling and therapeutic delivery. The summary then transitions to an analysis of structural disruptions, including trade policy influences and downstream distribution shifts, before concluding with pragmatic recommendations and methodological notes. Throughout, the emphasis remains on actionable insights that translate technical and regulatory complexity into clear implications for product development, sourcing, and market engagement.

A detailed examination of converging technological, regulatory, and procurement shifts that are redefining product expectations and supply chain priorities for vial adapters

The landscape for vial adapters is undergoing multiple simultaneous shifts that are reshaping product road maps and commercial approaches. Technological maturation is visible in the spread of safety-engineered designs and automated delivery interfaces, which are increasingly expected in higher acuity environments. Concurrently, material science advances enable lighter, more ergonomically friendly components that reduce device-related waste and improve handling in both point-of-care and home settings.

Regulatory emphasis on safe needleless access and compatibility testing is altering the cadence of product approvals and post-market surveillance obligations, thereby elevating quality systems and evidence generation as competitive differentiators. In procurement, buyers are placing greater weight on total cost of ownership, device lifecycle management, and supplier resilience. Finally, digital integration-ranging from track-and-trace identifiers to compatibility databases-has grown from a nice-to-have to a key enabler of inventory control and clinical compliance. Taken together, these transformative shifts favor manufacturers and distributors who can demonstrate safety, interoperability, and supply stability while supporting diverse channels and end-user environments.

An analytical perspective on how evolving tariff dynamics have shifted sourcing strategies, manufacturing footprints, and distribution resilience for vial adapter stakeholders

Recent trade measures and tariff dynamics originating from large importing economies have had a broad influence on the supply chains that feed vial adapter production and distribution. Tariff adjustments have amplified the importance of supply chain diversification, prompting many organizations to reassess component sourcing, manufacturing footprints, and inventory strategies to mitigate exposure to cross-border cost volatility. In response, procurement teams have accelerated supplier qualification activities and prioritized multi-sourcing to preserve continuity of supply.

Moreover, tariff-driven cost pressures have encouraged manufacturers to pursue design efficiencies and material substitutions where clinically permissible, while remaining attentive to regulatory compatibility and product performance. This in turn has spurred nearshoring conversations and selective relocation of assembly operations closer to major demand centers to reduce transit-dependent risk. At the same time, distributors and channel partners have adapted commercial terms and stocking practices to absorb short-term price impacts while maintaining predictable service levels for hospitals, clinics, and home care providers. Overall, the cumulative effect of tariff fluctuations has been to raise the strategic value of supply chain visibility, flexible manufacturing, and contractual agility across the ecosystem.

A comprehensive segmentation-driven analysis linking end-user settings, product types, delivery modes, channel structures, material choices, and clinical applications to strategic product positioning

Understanding market dynamics requires a segmentation-aware perspective that ties design and commercialization to specific use contexts and procurement pathways. By end user, adoption patterns differ between clinic environments, home care settings, and hospital systems, with hospital demand further split by the needs of large hospitals versus small hospitals; large hospitals typically prioritize integrated safety features and bulk procurement pathways while small hospitals often seek cost-effective, easy-to-deploy solutions. Product type divides offerings into conventional designs and safety-engineered variants, where safety devices command attention from risk-averse clinical protocols and programs focused on needlestick prevention.

Delivery mode influences operational fit, as automatic delivery interfaces are preferred when repeatability and reduced manual handling are critical, whereas manual devices retain appeal where simplicity and low maintenance are paramount. Channel considerations-direct sales relationships, distributor networks, and online platforms-shape commercial strategy by defining margins, reach, and post-sale support expectations. Material choices between metal and plastic affect durability, sterilization compatibility, and per-unit cost considerations, with each material class presenting distinct manufacturing and regulatory implications. Finally, application segmentation into diagnostic and therapeutic uses reveals different evidence and compatibility requirements; diagnostic workstreams include blood testing and vaccine administration where sample integrity and rapid handling matter, while therapeutic applications encompass drug delivery and immunotherapy where dosage precision, biocompatibility, and connector integrity are paramount. Integrating these segmentation lenses highlights where innovation investments, regulatory planning, and channel development are most likely to yield differentiated returns.

A regionally nuanced perspective on adoption drivers, regulatory variance, and distribution models across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics materially influence competitive advantage, supplier strategies, and adoption timelines, and should therefore inform market entry and expansion plans. In the Americas, procurement sophistication and consolidated hospital systems create opportunities for vendors who can demonstrate robust clinical evidence, integrated supply programs, and reliable logistics; regional distribution networks and group purchasing models often drive long-term contracts and expectations for value-added services. In Europe, Middle East & Africa, regulatory heterogeneity and a mix of centralized and decentralized procurement models require adaptive compliance strategies and flexible commercial approaches, particularly where national health authorities impose distinct compatibility or sterilization standards.

In the Asia-Pacific region, a combination of large manufacturing capabilities and rapidly growing home care adoption present unique opportunities for scale and cost leadership, while rising standards of clinical hygiene are increasing demand for safety-engineered products. Across all regions, differences in reimbursement mechanisms, contract structures, and clinical practice norms dictate tailored engagement models, and successful players will align product specifications, distribution partnerships, and service offerings to regional procurement rhythms and regulatory expectations.

Insights into competitive positioning, partnership models, and the operational capabilities that distinguish leading manufacturers and innovative entrants in the vial adapter arena

Competitive dynamics in the vial adapter space are shaped by a mix of established medical device manufacturers, specialist component producers, and innovative newcomers focused on safety and automation. Market leaders tend to differentiate through integrated quality systems, broad regulatory footprints, and the ability to support large institutional contracts with dependable logistics and post-market surveillance capabilities. Emerging firms often compete on nimbleness, introducing modular or digitally enabled solutions that respond quickly to clinical feedback and niche use cases.

Partnerships between device manufacturers and logistics or contract manufacturing organizations are increasingly common, as they allow firms to scale production rapidly while preserving quality control. Strategic collaborations with clinical networks and independent validation bodies also help to accelerate acceptance in hospital systems and clinics. From a competitive standpoint, success favors those who can demonstrate consistent compliance documentation, responsive customer support, and a clear roadmap for product evolution that aligns with clinical safety priorities and evolving delivery modalities.

Actionable strategic recommendations for manufacturers and suppliers to strengthen safety, supply resilience, clinical evidence generation, and channel alignment to drive adoption

Industry leaders should prioritize a set of pragmatic actions that align design choices, supply resilience, and commercial models with clinical and procurement realities. First, embed safety and compatibility testing early in the design lifecycle to reduce downstream regulatory friction and to strengthen customer value propositions. Second, diversify supplier bases for critical components and consider strategic nearshoring or regional assembly to mitigate transit and tariff-related exposure while shortening lead times.

Third, align channel strategies to customer preferences by balancing direct engagement for large institutional buyers with distributor and online models that serve clinics and home care markets efficiently. Fourth, invest in evidence generation and clinician engagement to demonstrate device performance across diagnostic and therapeutic applications, thereby smoothing adoption in both blood testing, vaccine administration, drug delivery, and immunotherapy workflows. Finally, build flexible commercial terms and service layers-such as training, compatibility support, and inventory management-to differentiate offerings and deepen customer relationships. Collectively, these actions will enhance resilience, accelerate adoption, and protect margins amid shifting external pressures.

A transparent multi-method research methodology integrating stakeholder interviews, regulatory analysis, and supply chain mapping to validate strategic insights and recommendations

The analysis underpinning this executive summary draws on a multi-method research approach that integrates primary stakeholder interviews, secondary literature review, regulatory filing analysis, and supply chain mapping. Primary engagements included structured conversations with procurement leaders, clinical end users, product development specialists, and distribution partners to surface practical adoption barriers, preference drivers, and service expectations. Secondary sources comprised regulatory guidance, industry best-practice documents, technical standards, and recent peer-reviewed literature addressing device safety, materials compatibility, and clinical workflows.

Complementing qualitative inputs, the methodology incorporated comparative analyses of manufacturing footprints and logistics pathways to identify points of supply fragility and potential efficiencies. Triangulation across these inputs ensured that thematic conclusions reflect both frontline practitioner experience and documented regulatory or technical constraints. Throughout the research, attention was given to methodological rigor: interview protocols were standardized, source provenance was tracked, and findings were iteratively validated with subject-matter experts to minimize bias and enhance reliability.

A conclusive synthesis emphasizing safety-led design, supply chain flexibility, and evidence-driven adoption as the pillars of durable competitive advantage for vial adapter stakeholders

In sum, vial adapter stakeholders face a landscape defined by rising safety expectations, material and design innovation, evolving procurement behavior, and the need for resilient, flexible supply chains. Those who align product development with rigorous compatibility testing, build diversified sourcing strategies, and tailor channel models to distinct end-user environments will be best positioned to capture sustained institutional and point-of-care adoption. Moreover, proactive engagement with clinical validators and investment in evidence generation will expedite integration into diagnostic and therapeutic workflows.

Looking ahead, maintaining agility in response to trade and regulatory shifts will be a critical determinant of operational continuity and competitive advantage. By translating the insights presented in this summary into targeted product enhancements, strategic supplier partnerships, and regionally calibrated go-to-market plans, organizations can strengthen their market positioning and support safer, more reliable access to injectable therapies and diagnostic procedures.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Vial Adapter Market, by End User

  • 8.1. Clinic
  • 8.2. Home Care
  • 8.3. Hospital

9. Vial Adapter Market, by Delivery Mode

  • 9.1. Automatic
  • 9.2. Manual

10. Vial Adapter Market, by Distribution Channel

  • 10.1. Offline
  • 10.2. Online

11. Vial Adapter Market, by Material

  • 11.1. Metal
  • 11.2. Plastic

12. Vial Adapter Market, by Application

  • 12.1. Diagnostic
    • 12.1.1. Blood Testing
    • 12.1.2. Vaccine Administration
  • 12.2. Therapeutic
    • 12.2.1. Drug Delivery
    • 12.2.2. Immunotherapy

13. Vial Adapter Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Vial Adapter Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Vial Adapter Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Vial Adapter Market

17. China Vial Adapter Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agilent Technologies Inc.
  • 18.6. Amsino International Inc.
  • 18.7. ARaymond
  • 18.8. B. Braun SE
  • 18.9. Baxter International Inc.
  • 18.10. Becton Dickinson and Company (BD)
  • 18.11. Cardinal Health, Inc.
  • 18.12. Corvida Medical
  • 18.13. Dedecke GmbH
  • 18.14. EQUASHIELD LLC
  • 18.15. Gerresheimer
  • 18.16. Helapet Limited
  • 18.17. ICU Medical
  • 18.18. MedXL Inc.
  • 18.19. Miltenyi Biotec B.V. & Co. KG
  • 18.20. Nipro Corporation
  • 18.21. Simplivia Healthcare Ltd.
  • 18.22. Stevanato Group S.p.A.
  • 18.23. Union Plastic S.A.S.
  • 18.24. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VIAL ADAPTER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VIAL ADAPTER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VIAL ADAPTER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VIAL ADAPTER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VIAL ADAPTER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VIAL ADAPTER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES VIAL ADAPTER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA VIAL ADAPTER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VIAL ADAPTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VIAL ADAPTER MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VIAL ADAPTER MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VIAL ADAPTER MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VIAL ADAPTER MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VIAL ADAPTER MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VIAL ADAPTER MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VIAL ADAPTER MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VIAL ADAPTER MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VIAL ADAPTER MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VIAL ADAPTER MARKET SIZE, BY AUTOMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VIAL ADAPTER MARKET SIZE, BY AUTOMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VIAL ADAPTER MARKET SIZE, BY AUTOMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VIAL ADAPTER MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VIAL ADAPTER MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VIAL ADAPTER MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VIAL ADAPTER MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VIAL ADAPTER MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VIAL ADAPTER MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VIAL ADAPTER MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VIAL ADAPTER MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VIAL ADAPTER MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VIAL ADAPTER MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VIAL ADAPTER MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VIAL ADAPTER MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VIAL ADAPTER MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VIAL ADAPTER MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VIAL ADAPTER MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VIAL ADAPTER MARKET SIZE, BY BLOOD TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VIAL ADAPTER MARKET SIZE, BY BLOOD TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VIAL ADAPTER MARKET SIZE, BY BLOOD TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VIAL ADAPTER MARKET SIZE, BY VACCINE ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VIAL ADAPTER MARKET SIZE, BY VACCINE ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VIAL ADAPTER MARKET SIZE, BY VACCINE ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VIAL ADAPTER MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VIAL ADAPTER MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VIAL ADAPTER MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VIAL ADAPTER MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VIAL ADAPTER MARKET SIZE, BY IMMUNOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VIAL ADAPTER MARKET SIZE, BY IMMUNOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VIAL ADAPTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS VIAL ADAPTER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA VIAL ADAPTER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL VIAL ADAPTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 128. GCC VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GCC VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 131. GCC VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. GCC VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. GCC VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. GCC VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 135. GCC VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 152. G7 VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. G7 VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. G7 VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 155. G7 VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. G7 VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. G7 VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. G7 VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 159. G7 VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 160. NATO VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. NATO VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. NATO VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 163. NATO VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. NATO VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. NATO VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. NATO VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 167. NATO VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES VIAL ADAPTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA VIAL ADAPTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)